miR-21-5p Inhibits Ferroptosis in Hepatocellular Carcinoma Cells by Regulating the AKT/mTOR Signaling Pathway through MELK
Journal of Immunology Research · 2023
DOI: 10.1155/2023/8929525 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Immunology Research, 2023. Verfasst von Zongqiang Hu und 6 weiteren Autor:innen. Beteiligte Einrichtung: First People's Hospital of Kunming City, Kunming 650032, Yunnan, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, MicroRNAs, Ferroptosis. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Reserve Talent Project for Young and Middle-aged Academic Technology Leaders in Yunnan Province, Yunnan Province Medical Discipline Leader Project.
Abstract (Originalsprache)
Background
Hepatocellular carcinoma (HCC) is one of the most prevalent cancers, and its incidence rate is increasing worldwide. At present, there is no ideal treatment for HCC. In recent years, molecular-targeted therapy has shown significant therapeutic benefits for patients. Ferroptosis is a modality of regulated cell death, and previous studies have found that inducing ferroptosis in liver cancer cells can inhibit the progression of liver cancer. The aim of this study is to investigate the regulatory mechanism of miR-21-5p in regulating ferroptosis in HCC cells.
Methods
CCK-8 was used to measure cell viability, EdU and colony formation were used to measure cell proliferation, and Transwell assays were used to measure cell migration and invasion. RT-qPCR was used to detect the level of miR-21-5p, Western blotting was used to detect the protein expression level, a dual-luciferase reporter gene assay was used to determine the targeting relationship between miR-21-5p and MELK, and coimmunoprecipitation was used to determine the interaction between MELK and AKT.
Results
Overexpression of miR-21-5p and MELK facilitated the viability, proliferation, colony formation, invasion, and migration of HCC cells. Downregulation of miR-21-5p suppressed the level of MELK and the progression of HCC. MELK regulated the AKT/mTOR signaling pathway, causing changes in the levels of GPX4, GSH, FTH1, xCT, heme oxygenase 1(HO-1), reactive oxygen species, and Fe2+ to regulate the ferroptosis of hepatoma cells. Erastin, an inducer of ferroptosis, attenuated the repressive influence of miR-21-5p on ferroptosis in HCC cells.
Conclusion
In summary, this study demonstrates that miR-21-5p inhibits the ferroptosis of HCC cells by regulating the AKT/mTOR signaling pathway through MELK.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- First People's Hospital of Kunming City, Kunming 650032, Yunnan, China.
- The Calmette Affiliated Hospital of Kunming Medical University, Kunming 650032, Yunnan, China.
ORCID-Profile: Zongqiang Hu, Jianghua Ran, Li Li
Förderung
- National Natural Science Foundation of China
- Reserve Talent Project for Young and Middle-aged Academic Technology Leaders in Yunnan Province
- Yunnan Province Medical Discipline Leader Project
- Kunming Medical University
- Spring City Plan: the High-level Talent Promotion and Training Project of Kunming
- Yunnan Kunming Chen Ceshi Expert Workstation
- Yunnan Xuxiao Expert Workstation
Zitieren
APA
Hu, Z., Li, L., Li, M., Zhang, X., Zhang, Y., Ran, J., & Li, L. (2023). miR-21-5p Inhibits Ferroptosis in Hepatocellular Carcinoma Cells by Regulating the AKT/mTOR Signaling Pathway through MELK. Journal of Immunology Research. https://doi.org/10.1155/2023/8929525
Vancouver
Hu Z, Li L, Li M, Zhang X, Zhang Y, Ran J, et al. miR-21-5p Inhibits Ferroptosis in Hepatocellular Carcinoma Cells by Regulating the AKT/mTOR Signaling Pathway through MELK. Journal of Immunology Research. 2023. doi:10.1155/2023/8929525
BibTeX
@article{Hu2023,
author = {Hu, Zongqiang and Li, Laibang and Li, Ma and Zhang, Xibing and Zhang, Yu and Ran, Jianghua and Li, Li},
title = {miR-21-5p Inhibits Ferroptosis in Hepatocellular Carcinoma Cells by Regulating the AKT/mTOR Signaling Pathway through MELK},
journal = {Journal of Immunology Research},
year = {2023},
doi = {10.1155/2023/8929525}
}
EUVIMED